NCT04929457

Evaluation of a Digiphysical Screening Method to Identify and Diagnose Familial Hypercholesterolemia

Evaluation of Digiphysical Screening for Familial Hypercholesterolemia - Efficacy of Digiphysical Screening, Effects on Cardiovascular Morbidity and Mortality and Health Economic Aspects

• Status: Enrolling By Invitation
• Phase: —
• Study type: Observational
• Enrollment: 30,000 (estimated)
• Sponsor: Karolinska Institutet · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Longitudinal and observational registry-based cohort study of individuals participating in the national digiphysical screening program for Familial Hypercholesterolemia. The information collected in the screening process will be combined in pseudo-anonymous form with data from the National Board of Health and Welfare (registries: Cause of Death, Diagnoses according to International Classification of Diseases (ICD) and Prescribed drugs) and Statistic Sweden (Longitudinal integrated database for health insurance and labour market studies). Primary analysis: association between Familial Hypercholesterolemia and cardiovascular disease. Secondary analysis: efficacy and health economic aspects of digiphysical screening for Familial Hypercholesterolemia.

Conditions

• Familial Hypercholesterolemia
• Hypercholesterolemia

Timeline

• Start date: 2021-09-01
• Primary completion: 2031-09-01
• Completion: 2033-09-01
• First posted: 2021-06-18
• Last updated: 2023-03-16

Locations

1 site across 1 country: Sweden